Key result
A seven-day prophylaxis with LMWH after cesarean delivery yielded the highest quality-adjusted life expectancy, with a net gain of 1.5-2.8 quality-adjusted days compared to no prophylaxis.
Why the study?
Does seven-day LMWH prophylaxis improve quality-adjusted life expectancy in women after cesarean delivery?
Does seven-day LMWH prophylaxis improve quality-adjusted life expectancy in women after cesarean delivery?
Effect estimate: net gain of 1.5-2.8 quality-adjusted days
A decision model suggests that 7-day LMWH prophylaxis after cesarean delivery provides a net benefit in quality-adjusted life expectancy, particularly for women with risk factors such as emergency procedure, BMI >25 kg/m², or smoking.
No takes yet. Share an insight, caveat, or question.
Supports modeled QALE gain with 7-day LMWH post-cesarean; leaves open confirmation in randomized trials before practice change.
Perrier et al. (2009) studied Post-cesarean delivery. Low-molecular-weight heparin (LMWH) was evaluated on Quality-adjusted life expectancy at three months (net gain of 1.5-2.8 quality-adjusted days). A seven-day prophylaxis with LMWH after cesarean delivery yielded the highest quality-adjusted life expectancy, with a net gain of 1.5-2.8 quality-adjusted days compared to no prophylaxis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: